Interest Coverage Ratio: 4.44x
Is the interest coverage ratio high or low?
The interest coverage ratio of 4.44x is 83% below its 5-year average of 26.02x, near the low end of its 5-year range (1.54x–62.22x).
As of Saturday, June 27, 2026. 8.47% below its 12-month average of 4.85x.
NRC Interest Coverage Ratio
Reported quarterly interest coverage; no daily interpolation.
NRC Average Interest Coverage Ratio Chart
NRC Current vs Average Interest Coverage Ratio Chart
NRC Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
4.44x
INTEREST COVERAGE RATIO AVG TTM
4.85x
INTEREST COVERAGE RATIO AVG 3Y
20.86x
INTEREST COVERAGE RATIO AVG 5Y
26.02x
INTEREST COVERAGE RATIO AVG 10Y
26.37x
INTEREST COVERAGE RATIO AVG 15Y
48.35x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.47%
CURRENT VS 3Y AVG
-78.73%
CURRENT VS 5Y AVG
-82.95%
CURRENT VS 10Y AVG
-83.17%
CURRENT VS 15Y AVG
-90.82%
CURRENT VS 20Y AVG
N/A
NRC Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 4.44x | 4.85x | 20.86x | 26.02x |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | -375.67x | N/A | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | -13.34x | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 2.86x | 2.86x | 2.86x | 6.42x |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 7.88x | 5.24x | 5.24x | 5.24x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | N/A | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | -22.52x | 2.41x | 2.41x | 2.41x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 5.52x | 5.51x | 7.63x | 62.06x |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 12.68x | 10.82x | 8.80x | 10.61x |
Financial Health Indicators
Interest Coverage
4.4x
Debt/Equity
5.65
Current Ratio
0.55
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Interest Coverage Ratio FAQ
- What is the interest coverage ratio for National Research Corporation (NRC)?
- The interest coverage ratio for NRC stock is 4.44x.
- Is National Research Corporation's interest coverage ratio high or low?
- The interest coverage ratio of 4.44x is 83% below its 5-year average of 26.02x, near the low end of its 5-year range (1.54x–62.22x).
- What is the TTM average interest coverage ratio for National Research Corporation (NRC)?
- The TTM average interest coverage ratio for NRC stock is 4.85x.
- What is the 3Y average interest coverage ratio for National Research Corporation (NRC)?
- The 3Y average interest coverage ratio for NRC stock is 20.86x.
- What is the 5Y average interest coverage ratio for National Research Corporation (NRC)?
- The 5Y average interest coverage ratio for NRC stock is 26.02x.
- What is the 10Y average interest coverage ratio for National Research Corporation (NRC)?
- The 10Y average interest coverage ratio for NRC stock is 26.37x.
- What is the 15Y average interest coverage ratio for National Research Corporation (NRC)?
- The 15Y average interest coverage ratio for NRC stock is 48.35x.
NRC Interest Coverage Ratio History
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 4.44x |
| 2025-12-31 | 3.41x |
| 2025-09-30 | 5.30x |
| 2025-06-30 | 1.54x |
| 2025-03-31 | 9.56x |
| 2024-12-31 | 13.15x |
| 2024-09-30 | 11.30x |
| 2024-06-30 | 15.97x |
| 2024-03-31 | 14.48x |
| 2023-12-31 | 43.69x |
| 2023-09-30 | 62.22x |
| 2023-06-30 | 48.78x |
| 2023-03-31 | 37.41x |
| 2022-12-31 | 42.80x |
| 2022-09-30 | 38.57x |
| 2022-06-30 | 36.15x |
| 2022-03-31 | 36.90x |
| 2021-12-31 | 32.27x |
| 2021-09-30 | 31.81x |
| 2021-06-30 | 28.93x |
| 2021-03-31 | 27.82x |
| 2020-12-31 | 22.79x |
| 2020-09-30 | 26.65x |
| 2020-06-30 | 20.61x |
| 2020-03-31 | 24.07x |
| 2019-12-31 | 25.03x |
| 2019-09-30 | 20.04x |
| 2019-06-30 | 19.04x |
| 2019-03-31 | 18.78x |
| 2018-12-31 | 18.00x |
| 2018-09-30 | 16.85x |
| 2018-06-30 | 17.67x |
| 2018-03-31 | 1119.75x |
| 2017-12-31 | 618.64x |
| 2017-09-30 | 395.67x |
| 2017-06-30 | 367.48x |
| 2017-03-31 | 369.78x |
| 2016-12-31 | 276.06x |
| 2016-09-30 | 193.13x |
| 2016-06-30 | 194.94x |
| 2016-03-31 | 94.19x |
| 2015-12-31 | 160.54x |
| 2015-09-30 | 125.92x |
| 2015-06-30 | 111.65x |
| 2015-03-31 | 92.52x |
| 2014-12-31 | 93.03x |
| 2014-09-30 | 94.20x |
| 2014-06-30 | 81.00x |
| 2014-03-31 | 103.70x |
| 2013-12-31 | 68.49x |
| 2013-09-30 | 66.25x |
| 2013-06-30 | 54.79x |
| 2013-03-31 | 61.68x |
| 2012-12-31 | 46.19x |
| 2012-09-30 | 42.14x |
| 2012-06-30 | 37.26x |
| 2012-03-31 | 42.83x |
| 2011-12-31 | 33.62x |
| 2011-09-30 | 27.06x |
| 2011-06-30 | 24.56x |
| 2011-03-31 | 33.73x |
| 2010-12-31 | 14.47x |
| 2010-09-30 | 25.50x |
| 2010-06-30 | 28.58x |
| 2010-03-31 | 54.56x |
| 2009-12-31 | 36.53x |
| 2009-09-30 | 36.24x |
| 2009-06-30 | 31.79x |
| 2009-03-31 | 31.68x |
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green